An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO ®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany
Conditions: Resectable Non-small Cell Lung Cancer Interventions: Drug: Neoadjuvant nivolumab in combination with platinum-based chemotherapy Sponsors: Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Germany Health | Lung Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Non-Small Cell Lung Cancer | Research | Study